Huron Consulting Group Inc. $HURN Shares Acquired by Invesco Ltd.

Key Points

• Invesco Ltd. increased its stake in Huron Consulting Group by 7.9%, owning 282,017 shares valued at approximately $40.5 million as of its latest SEC filing.
• Huron Consulting Group reported earnings of $1.89 per share for the last quarter, surpassing analysts' expectations of $1.79, while its revenue increased by 8.3% year-over-year.
• Institutional investors own a significant 93.90% of Huron Consulting Group's stock, indicating strong confidence from larger investment funds.

Invesco Ltd. grew its position in shares of Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) by 7.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 282,017 shares of the business services provider's stock after purchasing an additional 20,680 shares during the period. Invesco Ltd. owned approximately 1.64% of Huron Consulting Group worth $40,455,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. Opal Wealth Advisors LLC bought a new position in shares of Huron Consulting Group in the 1st quarter valued at about $35,000. Heck Capital Advisors LLC bought a new position in shares of Huron Consulting Group in the 4th quarter valued at about $33,000. CWM LLC lifted its holdings in shares of Huron Consulting Group by 55.9% in the 1st quarter. CWM LLC now owns 407 shares of the business services provider's stock valued at $58,000 after acquiring an additional 146 shares during the last quarter. Vestcor Inc bought a new position in shares of Huron Consulting Group in the 1st quarter valued at about $60,000. Finally, Tower Research Capital LLC TRC lifted its holdings in shares of Huron Consulting Group by 27.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 569 shares of the business services provider's stock valued at $71,000 after acquiring an additional 122 shares during the last quarter. Hedge funds and other institutional investors own 93.90% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on HURN. Wall Street Zen downgraded shares of Huron Consulting Group from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Barrington Research raised their price objective on shares of Huron Consulting Group from $173.00 to $176.00 and gave the stock an "outperform" rating in a research note on Thursday, August 7th. Five equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Huron Consulting Group has a consensus rating of "Buy" and a consensus target price of $171.50.

Huron Consulting Group Trading Up 1.9%

Shares of Huron Consulting Group stock traded up $2.53 on Friday, hitting $137.92. 74,497 shares of the company traded hands, compared to its average volume of 202,087. The stock's 50 day moving average price is $133.59 and its 200-day moving average price is $138.81. The company has a current ratio of 1.99, a quick ratio of 1.99 and a debt-to-equity ratio of 1.35. Huron Consulting Group Inc. has a 52 week low of $102.58 and a 52 week high of $155.00. The company has a market cap of $2.39 billion, a PE ratio of 24.07 and a beta of 0.26.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The business services provider reported $1.89 EPS for the quarter, topping analysts' consensus estimates of $1.79 by $0.10. The company had revenue of $402.50 million during the quarter, compared to the consensus estimate of $402.67 million. Huron Consulting Group had a net margin of 6.60% and a return on equity of 25.52%. Huron Consulting Group's revenue for the quarter was up 8.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.68 earnings per share. Huron Consulting Group has set its FY 2025 guidance at 7.300-7.70 EPS. Equities research analysts predict that Huron Consulting Group Inc. will post 6.1 EPS for the current year.

Insider Buying and Selling at Huron Consulting Group

In related news, Director H Eugene Lockhart sold 1,040 shares of the business's stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $136.74, for a total value of $142,209.60. Following the completion of the transaction, the director owned 8,162 shares of the company's stock, valued at $1,116,071.88. The trade was a 11.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director James H. Roth sold 2,000 shares of the business's stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $128.98, for a total transaction of $257,960.00. Following the completion of the transaction, the director directly owned 43,304 shares of the company's stock, valued at $5,585,349.92. This trade represents a 4.41% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 4,711 shares of company stock worth $624,066. 2.15% of the stock is currently owned by corporate insiders.

Huron Consulting Group Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.